Contributed by Ashok Kumar, PhD, CFA

Key Points

Bimergen Energy is a pre-commercial BESS developer, not yet an operating IPP. The 2025 10-K states that as of December 31, 2025, the company had not commenced commercial operations or generated revenue, while its acquired portfolio included 23 utility-scale BESS projects totaling 1.965 GW / 7.860 GWh and 13 solar projects totaling 1.640 GW. Our BUY case rests on whether a small public equity base can capture value as selected projects move through financing, procurement, construction, and dispatch. We think the public record supports a $10 target under probability-weighted NAV, but not $15 as a base case.

Operations

The strongest near-term evidence remains Redbird and the ERCOT South DG portfolio, in our view. Redbird, a 100 MW / 400 MWh Texas project, was accepted under the Eos JDA and selected Eos Z3 zinc-based technology. The filed Redbird financing path includes a non-binding ITC transfer term sheet for up to $80 million of federal credits, with approximately $78 million anticipated, subject to diligence, definitive documents, and finding a purchaser. Management later stated that a typical 100 MW project now costs about $125 million, produces about $20 million in annual arbitrage revenue, and can monetize roughly $60 million of ITCs. We treat those as verbal targets, not model inputs that override the filed $160 million Redbird project-cost table.

Schedule and Revenue Risk

Timelines are funding- and procurement-gated. The S-1/A states battery and connection component procurement is expected to take 6–9 months after funding, with construction taking another 2–3 months after funding and component arrival. The DG acquisition added eight late-stage 9.9 MW ERCOT South projects, or 79.2 MW total, financed through the RelyEZ JV, and the TruGrid award covers 40 MW / 80 MWh. The investor deck presents $250 million committed capital, “100% project financing,” offtake/tolling structures, and ~50% ITC agreements, but filings still control where project financing or offtake is not yet final.

Financials and Capitalization

For 2025, Bimergen reported zero revenue, $4.9 million of G&A expense, and a $5.0 million net loss. Year-end cash was about $0.4 million, current assets were $3.3 million, current liabilities were $7.8 million, and working capital was negative $4.5 million. We now model 2026E revenue of $15.0 million, $7.5 million cost of revenue, $7.5 million gross profit, $6.0 million G&A, and $1.5 million net income, or about $0.21 per basic share. This is our estimate, not company guidance, and should be treated as grant/ development-related revenue rather than recurring BESS operating revenue.

Execution and Risk

The February 2026 offering raised $13.6 million gross through 3.1 million shares, 300,000 pre-funded warrants, and 3.6 million warrants. Current basic shares were 7.073 million as of March 31, 2026; our target-price diluted denominator remains about 12.56 million. The April 3 prospectus supplement adds resale-overhang context but does not change the denominator. GridSpan adds useful liquidity context but also milestone risk: the 10-K discloses a $3.564 million advance recorded as deferred revenue, no NTP or project-title transfer as of year-end, and a contingent refund obligation if specified financing and project milestones are not met by June 30, 2026. Bimergen also has up to $12.5 million of RelyEZ/ GridSpan capital-call exposure.

Summary

Our $10.00 PT is based on diluted, probability-weighted project NAV, not DCF or a 2028 EBITDA multiple. The defensible wording is BUY with elevated development-stage execution risk. Required evidence for a higher target remains binding offtake, project debt, ITC transfer execution, COD progress, GridSpan milestone satisfaction, and clearer retained economics.

For full report, please click here.